About Avinger
Avinger is a company based in Redwood City (United States) founded in 2007.. Avinger has raised $170.85 million across 10 funding rounds from investors including Zylox-Tonbridge, CRG and PDL BioPharma. Avinger offers products and services including Pantheris, Ocelot, TigerEye, and Lightbox. Avinger operates in a competitive market with competitors including Pathway Medical Technologies, Intact Vascular, LeMaitre Vascular, Cagent Vascular and Okami Medical, among others.
- Headquarter Redwood City, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$170.85 M (USD)
in 10 rounds
-
Latest Funding Round
$15 M (USD), Post-IPO
Mar 22, 2024
-
Investors
Zylox-Tonbridge
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Avinger
Avinger offers a comprehensive portfolio of products and services, including Pantheris, Ocelot, TigerEye, and Lightbox. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Image-guided tool for directional atherectomy in vascular disease.
Device for crossing chronic total occlusions with real-time imaging.
Provides onboard imaging for precise vascular interventions.
Console for operating image-guided vascular devices.
Unlock access to complete
Unlock access to complete
Funding Insights of Avinger
Avinger has successfully raised a total of $170.85M across 10 strategic funding rounds. The most recent funding activity was a Post-IPO round of $15 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Post-IPO — $15.0M
-
First Round
First Round
(01 Dec 2010)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2024 | Amount | Post-IPO - Avinger | Valuation |
investors |
|
| Mar, 2022 | Amount | Post-IPO - Avinger | Valuation |
investors |
|
| Sep, 2014 | Amount | Series E - Avinger | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Avinger
Avinger has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Zylox-Tonbridge, CRG and PDL BioPharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CRG is recognized as a premier healthcare investment partner.
|
Founded Year | Domain | Location | |
|
Biopharmaceutical company undergoing dissolution and asset distribution processes.
|
Founded Year | Domain | Location | |
|
Medical equipment is manufactured by Zylox-Tonbridge in Hangzhou, China.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Avinger
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Avinger
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Avinger Comparisons
Competitors of Avinger
Avinger operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pathway Medical Technologies, Intact Vascular, LeMaitre Vascular, Cagent Vascular and Okami Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Smart devices are provided to clear peripheral arterial blockages.
|
|
| domain | founded_year | HQ Location |
Implants for repairing arteries after angioplasty are developed.
|
|
| domain | founded_year | HQ Location |
Devices for peripheral vascular disease treatment are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Devices for removing vascular blockages are developed.
|
|
| domain | founded_year | HQ Location |
Innovative medical devices for peripheral vessel treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Avinger
Frequently Asked Questions about Avinger
When was Avinger founded?
Avinger was founded in 2007 and raised its 1st funding round 3 years after it was founded.
Where is Avinger located?
Avinger is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Is Avinger a funded company?
Avinger is a funded company, having raised a total of $170.85M across 10 funding rounds to date. The company's 1st funding round was a Series E of $34.83M, raised on Dec 01, 2010.
What does Avinger do?
Avinger was founded in 2007 as a commercial-stage medical device company based in Redwood City, United States. Catheter-based products guided by imaging technology are developed, manufactured, and sold for the treatment of peripheral artery disease. The product range includes the Lightbox imaging console and catheters such as Wildcat, Kittycat, and Ocelot, supporting interventions in the vascular sector.
Who are the top competitors of Avinger?
Avinger's top competitors include Okami Medical, Cagent Vascular and LeMaitre Vascular.
What products or services does Avinger offer?
Avinger offers Pantheris, Ocelot, TigerEye, and Lightbox.
Who are Avinger's investors?
Avinger has 3 investors. Key investors include Zylox-Tonbridge, CRG, and PDL BioPharma.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.